Combination antibiotic therapy versus monotherapy for gram-negative bacteraemia: a commentary

Area of Science:

• Infectious Diseases
• Microbiology
• Clinical Pharmacology

Background:

• Gram-negative bacteraemia treatment efficacy is debated.
• Combination antimicrobial therapy offers theoretical advantages supported by preclinical data.
• Clinical evidence for combination therapy in gram-negative bacteraemia remains conflicting.

Purpose of the Study:

• To evaluate the efficacy of combination antimicrobial therapy versus monotherapy for gram-negative bacteraemia.
• To identify patient subgroups or specific pathogens that may benefit from combination therapy.

Main Methods:

• Review of selected clinical studies on gram-negative bacteraemia.
• Analysis of patient outcomes based on treatment regimen (combination vs. monotherapy).
• Stratification of results by patient severity and causative bacterial species.

Main Results:

• Combination therapy did not show universal superiority over monotherapy.
• Improved outcomes with combination therapy were observed primarily in severely ill patients.
• Efficacy of combination therapy was potentially restricted to bacteraemia caused by Pseudomonas aeruginosa, Klebsiella spp., or Enterobacter spp.

Conclusions:

• Combination antimicrobial therapy for gram-negative bacteraemia is not consistently more effective than monotherapy.
• Severely ill patients and those with specific Gram-negative pathogens may represent a niche for combination therapy.
• Further research is needed to define optimal treatment strategies for gram-negative bacteraemia.